Overview
Reiko Tanaka practices practicing medicine in Orsay, France.
Ms. Tanaka is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Atopic Dermatitis, Squamous Cell Skin Carcinoma, and Asthma.
She is actively involved in clinical research, co-authoring 280 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Reiko J. Tanaka
Is Reiko J. Tanaka a top-rated expert for Atopic Dermatitis?
MediFind is an objective health platform that identifies experts based on real-world data. Reiko J. Tanaka is classified as an Advanced expert for Atopic Dermatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Reiko J. Tanaka participate in research or clinical trials?
Yes. Reiko J. Tanaka has published 280 articles and abstracts on conditions like Atopic Dermatitis. You can view a list of Reiko J. Tanaka's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Atopic DermatitisMs. Tanaka isAdvanced. Learn about Atopic Dermatitis.
- Experienced
- AsthmaMs. Tanaka isExperienced. Learn about Asthma.
- Squamous Cell Skin CarcinomaMs. Tanaka isExperienced. Learn about Squamous Cell Skin Carcinoma.